Showing results (201-210 of 235) with videos related to
Sort By:
Pageof 24
Cell Reports. Medicine|February 10, 2024
Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinomaThomas Pulliam, Saumya Jani, Lichen Jing, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2017
Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ SubjectsChike O Abana, Mark A Pilkinton, Silvana Gaudieri, et al.Journal of Virology|May 29, 2015
Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2Ruchi M Newman, Susanna L Lamers, Brian Weiner, et al.The Journal of Infectious Diseases|May 7, 2019
A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV InfectionLesia K Dropulic, Makinna C Oestreich, Harlan L Pietz, et al.Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severityRebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.JCI Insight|June 22, 2021
Distinct populations of antigen-specific tissue-resident CD8+ T cells in human cervix mucosaTao Peng, Khamsone Phasouk, Emily Bossard, et al.Biorxiv : the Preprint Server for Biology|February 19, 2024
T-cells specific for KSHV and HIV migrate to Kaposi sarcoma tumors and persist over timeShashidhar Ravishankar, Andrea M H Towlerton, Iyabode L Tiamiyu, et al.Medrxiv : the Preprint Server for Health Sciences|February 4, 2022
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific componentsLichen Jing, Xia Wu, Maxwell P Krist, et al.JCI Insight|February 8, 2022
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific componentsLichen Jing, Xia Wu, Maxwell P Krist, et al.JCI Insight|August 12, 2024
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccineEmily S Ford, Alvason Z Li, Kerry J Laing, et al.Pageof 24